RNA Transcriptome Profiling Test Market

Table of Content

• 1. Executive Summary
• 2. Industry Introduction, including Taxonomy and Market Definition
• 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
• 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
  • 5.1. by Component Type
  • 5.2. by Method Type
  • 5.3. by Application
  • 5.4. by End User
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Component Type
  • 6.1. Consumables
    • 6.1.1. Reagents
    • 6.1.2. Kits
    • 6.1.3. Dyes
  • 6.2. Instruments
    • 6.2.1. RT PCR
    • 6.2.2. Microarray
    • 6.2.3. Sanger Sequencing Platform
    • 6.2.4. RNA Sequencing Platform
  • 6.3. Software
  • 6.4. Services
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Method Type
  • 7.1. Conventional Methods
    • 7.1.1. RNA-DNA Hybridization Measurements
    • 7.1.2. Subtractive Hybridization
    • 7.1.3. Differential Display
  • 7.2. High Throughput Methods
    • 7.2.1. Hybridization-based method using Micro Array Technology
    • 7.2.2. Sequencing based
      • 7.2.2.1. RNA sequencing
      • 7.2.2.2. Serial analysis of gene expression (SAGE)
      • 7.2.2.3. Massively Parallel Signature Sequencing (MPSS)
• 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application
  • 8.1. Cancer Research
  • 8.2. Complex Disease Biomarker Identification
  • 8.3. Agrigenomics
  • 8.4. RNA-Based Drug Response Biomarker Discovery
  • 8.5. Others
• 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User
  • 9.1. Hospital Based Laboratories
  • 9.2. Diagnostic Centers
  • 9.3. Academic and Research Institutes
  • 9.4. Contract research Organizations (CROs)
  • 9.5. Others
• 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
  • 10.1. North America
  • 10.2. Latin America
  • 10.3. Western Europe
  • 10.4. Eastern Europe
  • 10.5. East Asia
  • 10.6. South Asia & Pacific
  • 10.7. MEA
• 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
• 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
• 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
• 14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
• 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
• 16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
• 17. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
• 18. Sales Forecast 2024 to 2034, by Component Type, by Method Type, by Application, and by End User for 30 Countries
• 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
• 20. Company Profile
  • 20.1. Agilent Technologies, Inc.
  • 20.2. F. Hoffmann-La Roche AG
  • 20.3. Illumina, Inc.
  • 20.4. Thermo Fisher Scientific, Inc.
  • 20.5. QIAGEN N.V.
  • 20.6. Bio-Rad Laboratories, Inc.
  • 20.7. Pacific Biosciences of California, Inc.
  • 20.8. Eurofins Scientific
  • 20.9. Merck KGaA
  • 20.10. Promega Corporation
  • 20.11. 10x Genomics
  • 20.12. Twist Bioscience
  • 20.13. Bruker Spatial Biology
  • 20.14. Cepheid